What is SCH-900776 used for?

SCH-900776 is being studied for use in treating various blood cancers like Hodgkin lymphoma, non-Hodgkin lymphoma, and different types of leukemia.

Is SCH-900776 an approved medicine?

No, SCH-900776 is currently an experimental drug in Phase 2 clinical trials and is not yet approved for public use.

What types of leukemia can SCH-900776 treat?

Research is looking into its effectiveness against acute lymphoblastic leukemia, acute myeloid leukemia, and chronic myelogenous leukemia.

What kind of molecule is SCH-900776?

SCH-900776 is classified as a small molecule drug.

Is SCH-900776 safe for children?

Information regarding the use of SCH-900776 in pediatric patients is not currently available in the provided data.

Are there known side effects for SCH-900776?

Specific side effects for SCH-900776 have not been listed in the current clinical summary provided.

Sch-900776 | CAS 891494-63-6 | GMIZZEXBPRLVIV

Loading compound...

Experimental small molecule cancer therapy

SCH-900776 is an experimental small molecule drug currently being studied in clinical research. It is being investigated for its potential to treat various types of blood cancers, including several forms of leukemia and lymphoma.

How it worksSCH-900776 is a small molecule designed to target specific biological processes in cancer cells, though the exact mechanism is still under investigation in clinical phases.

Used for

Hodgkin lymphomaAcute lymphoblastic leukemiaAcute myeloid leukemiaChronic myelogenous leukemiaNon-Hodgkin lymphoma

Conditions

Hodgkin lymphomaacute lymphoblastic leukemiaacute myeloid leukemiachronic myelogenous leukemianon-Hodgkins lymphoma

Class

Small moleculeAntineoplasticExperimental small molecule cancer therapyHematologic

How to take

This drug is currently in Phase 2 clinical trials and is not yet FDA-approved for general use.

Talk to your doctor

Questions to ask

·Is SCH-900776 part of any clinical trials I might qualify for?
·How does this experimental drug differ from my current leukemia treatment?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)